Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.180
+0.020 (1.72%)
Jan 28, 2026, 12:06 PM EST - Market open
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $9.26 million as of January 28, 2026. Its market cap has decreased by -39.91% in one year.
Market Cap
9.26M
Enterprise Value
6.61M
1-Year Change
-39.91%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.28M to $9.26M, a decrease of -95.31%. That is a compound annual growth rate of -46.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 9.10M | -3.33% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.17% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | 197.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 10.34M |
| BioRestorative Therapies | 10.12M |
| Pulmatrix | 9.71M |
| PharmaCyte Biotech | 9.51M |
| XTL Biopharmaceuticals | 9.35M |
| SeaStar Medical Holding | 9.30M |
| BioVie | 9.20M |
| MetaVia | 9.08M |